Global M&A Intelligence Report 2023 – Life Sciences Supplement
An analysis of the trends, challenges and opportunities in the global life sciences M&A marketThis report provides an insight into life sciences M&A deal activity in 2022 and supplements our 2023 global M&A intelligence report, which is now in its ninth edition.
The life sciences sector is broad and captures a number of sub-sectors, including pharmaceutical, medical devices and biotech.
The report looks at a selection of our international corporate life sciences transactions to identify trends and developments, which can provide insightful intelligence for those operating in the sector and considering M&A activity, both domestically or internationally.
The report focuses on five key themes:
- Due Diligence (DD)
- Warranty and Indemnity (W&I) insurance
- Transaction structures
- Trade v Private Equity
- US v Rest of the World (RoW)